Skip to content
Menu

Oracle Launches Life Sciences AI Agents To Work On Clinical Trial Operations

Benzinga Newsdesk 9 hours ago

News

By bringing together insights from Oracle Life Sciences applications and supported third-party data sources, the agents are designed to help clinical trial teams identify operational issues, recommend appropriate actions for review and approval, and coordinate responses across clinical development workflows. For example, an agent can monitor study performance, likely drivers of KPI variances, and recommend operational actions that follow trial protocol.

Available today for early adopters, Oracle Life Sciences AI Agents focus on portfolio monitoring, trial planning, and trial conduct. Planned enhancements are intended to extend AI-assisted capabilities into clinical development domains, including clinical data management, post-trial analytics, trial design, and post-market workflows. The new AI Agents are designed to operate with human oversight, with humans responsible for reviewing recommendations and approving proposed actions before execution.

Read at benzinga.com